TORO CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TORO CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $539.30M | Dec 21, 2018 |
| FY2018 | Aug 3, 2018 | $655.82M | Dec 21, 2018 |
| FY2018 | May 4, 2018 | $875.28M | Dec 21, 2018 |
| FY2018 | Feb 2, 2018 | $548.25M | Dec 21, 2018 |
| FY2018 | Oct 31, 2017 | $488.63M | Dec 21, 2018 |
| FY2018 | Aug 4, 2017 | $627.94M | Dec 21, 2018 |
| FY2018 | May 5, 2017 | $872.77M | Dec 21, 2018 |
| FY2018 | Feb 3, 2017 | $515.84M | Dec 21, 2018 |
| FY2018 | Oct 31, 2016 | $2.39B | Dec 21, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.51B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $4.58B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $4.55B | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $4.51B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $3.96B | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $840.96M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $840.97M | Dec 18, 2020 |
| FY2020 | May 1, 2020 | $929.40M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $767.48M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $734.38M | Dec 18, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $488.63M | Dec 22, 2017 |
| FY2017 | Aug 4, 2017 | $627.94M | Dec 22, 2017 |
| FY2017 | May 5, 2017 | $872.77M | Dec 22, 2017 |
| FY2017 | Feb 3, 2017 | $515.84M | Dec 22, 2017 |
| FY2017 | Oct 31, 2016 | $468.36M | Dec 22, 2017 |
| FY2017 | Jul 29, 2016 | $600.98M | Dec 22, 2017 |
| FY2017 | Apr 29, 2016 | $836.44M | Dec 22, 2017 |
| FY2017 | Jan 29, 2016 | $486.40M | Dec 22, 2017 |
| FY2016 | Oct 31, 2015 | $480.81M | Dec 22, 2016 |
| FY2016 | Jul 31, 2015 | $609.62M | Dec 22, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.50B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.55B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $1.58B | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $1.50B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $1.34B | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $300.40M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $294.57M | Dec 18, 2020 |
| FY2020 | May 1, 2020 | $306.72M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $288.09M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $245.07M | Dec 18, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $316.10M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $418.90M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $329.70M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $443.30M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $409.90M | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $72.20M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $88.97M | Dec 18, 2020 |
| FY2020 | May 1, 2020 | $98.45M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $70.09M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $38.27M | Dec 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $409.90M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $533.30M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $430.70M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $575.70M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $518.30M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $426.36M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $325.03M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $373.09M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $355.11M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $334.40M | Dec 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $162.30M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $173.10M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $173.90M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $155.60M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $141.00M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $124.10M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $109.10M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $83.50M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $80.40M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $77.40M | Dec 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.01B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.02B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $995.60M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $928.90M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $820.20M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $763.42M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $722.93M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $567.93M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $565.73M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $540.20M | Dec 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $662.00M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $569.90M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $306.80M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $297.20M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $555.50M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $539.37M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $337.37M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $364.81M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $360.75M | Dec 20, 2019 |
| FY2010 | Oct 31, 2010 | $193.51M | Dec 22, 2010 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $83.70M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $103.50M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $149.50M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $143.50M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $104.00M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $78.07M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $92.88M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $90.12M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $58.28M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $50.72M | Dec 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.44B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $3.58B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $3.64B | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $3.56B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $2.94B | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $2.85B | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $2.33B | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $1.57B | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $1.49B | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $1.38B | Dec 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.45B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.55B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $1.51B | Dec 17, 2025 |
| FY2025 | Oct 31, 2022 | $1.35B | Dec 17, 2025 |
| FY2024 | Oct 31, 2021 | $1.15B | Dec 18, 2024 |
| FY2023 | Oct 31, 2020 | $1.11B | Dec 20, 2023 |
| FY2022 | Oct 31, 2019 | $859.58M | Dec 22, 2022 |
| FY2021 | Oct 31, 2018 | $668.92M | Dec 17, 2021 |
| FY2020 | Oct 31, 2017 | $617.09M | Dec 18, 2020 |
| FY2019 | Oct 31, 2016 | $550.04M | Dec 20, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $450.90M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $450.30M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $450.80M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $583.30M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $421.70M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $424.08M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $362.25M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $225.29M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $205.03M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $194.78M | Dec 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.39B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.50B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $1.44B | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $1.28B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $1.07B | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $1.04B | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $784.89M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $587.25M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $534.33M | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | $480.04M | Dec 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $289.12M | Dec 21, 2018 |
| FY2018 | Oct 31, 2017 | $310.26M | Dec 21, 2018 |
| FY2018 | Oct 31, 2016 | $273.56M | Dec 21, 2018 |
| FY2018 | Oct 31, 2015 | $126.28M | Dec 21, 2018 |
| FY2017 | Oct 31, 2014 | $314.87M | Dec 22, 2017 |
| FY2016 | Oct 31, 2013 | $182.99M | Dec 22, 2016 |
| FY2015 | Oct 31, 2012 | $125.86M | Dec 23, 2015 |
| FY2014 | Oct 31, 2011 | $80.89M | Dec 22, 2014 |
| FY2013 | Oct 31, 2010 | $177.37M | Dec 20, 2013 |
| FY2012 | Oct 31, 2009 | $187.77M | Dec 21, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $921.50M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $921.80M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $1.03B | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $990.80M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $691.24M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $791.12M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $700.81M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $312.55M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $331.89M | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | $350.96M | Dec 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 3 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 4 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 3 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 4 | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | 3 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | May 1, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | 0 | Dec 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 3 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 4 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 3 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 4 | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | 3 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | May 1, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | 0 | Dec 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 97.89M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 101.47M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | 103.84M | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | 103.97M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | 105.21M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | 107.58M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | 106.74M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | 105.60M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | 106.88M | Dec 21, 2018 |
| FY2017 | Oct 31, 2016 | 108.43M | Dec 22, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $151.10M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $149.50M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $141.90M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $125.70M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $112.40M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $107.70M | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $96.13M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $85.03M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $75.76M | Dec 20, 2019 |
| FY2018 | Oct 31, 2016 | $65.89M | Dec 21, 2018 |